

RETATRUTIDE 10 MG INJECTION
Drug Class: Triple Agonist (GLP-1 + GIP + Glucagon Receptor Agonist)
Composition:
- Active Substance: Retatrutide
- Concentration: 10 mg/vial
Presentation: 2 mL Vial
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
Retatrutide is a novel multi-agonist peptide targeting GLP-1, GIP, and glucagon receptors to promote powerful weight loss and metabolic enhancement. Designed for subcutaneous injection, this 10 mg vial by Dragon Pharma is a cutting-edge solution for obesity management, appetite suppression, and glucose regulation.
Recent clinical trials have shown Retatrutide to reduce body weight by up to 24% in obese individuals. It outperforms semaglutide and tirzepatide in early studies. Read the Phase 2 results published in NEJM.
This peptide is being explored as a next-generation obesity therapy with broad metabolic and hormonal benefits—without the need for stimulants or strict dieting.
Reconstitute with 1–2 mL of bacteriostatic water. Administer via subcutaneous injection once weekly. Initial doses often start at 0.5–1 mg/week and gradually titrate to a full dose of up to 8–12 mg/week based on individual response and tolerance.
Injections should be done consistently on the same day each week. Best injected in the abdomen or thigh.
Retatrutide can be stacked with non-overlapping peptides for advanced body transformation or wellness goals:
This innovative GLP-1/GIP/glucagon agonist from Dragon Pharma offers a clinical-grade edge in fat loss therapy.
Most common side effects include nausea, fatigue, constipation, or decreased appetite—typically during the titration period. These symptoms usually resolve after the first few weeks. Always consult a licensed provider before starting any GLP-1-based therapy.
Retatrutide 10 mg for Sale is a game-changing weight loss peptide engineered for powerful body fat reduction, hormonal regulation, and appetite control. This advanced Dragon Pharma formulation supports sustainable transformation in those serious about fat loss and metabolic health.
Retatrutide is a triple agonist peptide used to promote weight loss, reduce appetite, and improve glucose control. It targets GLP-1, GIP, and glucagon receptors for broad metabolic effects.
In clinical studies, Retatrutide has shown body fat reduction of up to 24% in obese patients—outperforming many current GLP-1 agonists like semaglutide or tirzepatide.
Retatrutide is injected subcutaneously once per week. Start with a low dose (0.5–1 mg/week) and gradually increase to full dosage as tolerated under medical supervision.
Common side effects include nausea, constipation, low appetite, or fatigue. These effects are usually mild and subside after initial dose adjustment.
Please log in to write Retatrutide 10 mg review.
PENTADECAPEPTIDE 2 MG INJECTION
Drug Class: Healing/Repair Peptide
Composition:
- Active Substance: Pentadecapeptide
- Concentration: 5 mg/vial
Presentation: 5 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report
TIRZE-PEP 5 MG INJECTION
Drug Class: Dual GLP-1/GIP Peptide
Composition:
- Active Substance: Tirzepatide
- Concentration: 5 mg/vial
Presentation: 2 mL Vial
Form: Powder
Manufacturer: Dragon Pharma
Tested in Laboratory: View Lab Report